Ms. Stephanie Holland previously managed Clinical Programs in therapeutic areas covering Influenza, Oncology, Hepatitis B and Anthrax at Altimmune, Inc. She has held various positions in biotech and public health organizations managing the execution of global Phase I-IV clinical trials. At APT she leverages her knowledge of clinical research processes to strategically execute clinical programs […]
Clinical & Regulatory Leadership
Stephanie Holland
Amy Fix
Ms. Amy Fix is responsible for regulatory strategy and interactions with regulatory agencies, including the U.S. Food and Drug Administration and the European Medicines Agency. Ms. Fix was previously Senior Vice President of Regulatory Affairs at Novavax (NYSE: NVAX), where she led the development of multiple late-stage vaccine programs, including a Phase 3 global maternal […]
Robert J. Hopkins
Dr. Bob Hopkins previously served as Senior Medical Advisor in the Division of Clinical Services (DCS) for the Biomedical Advanced Research and Development Authority (BARDA), Washington DC. Prior to that he has held various roles including Director of Clinical Research at Merck Research Laboratories, Vice President of Product Development at Aeras, and team leader at […]
Michael Brownstein
Dr. Michael Brownstein, a National Institutes of Health (NIH) Emeritus Scientist, served as the Chief of the Laboratory of Genetics of the National Institute of Mental Health and the National Human Genome Research Institute in addition to two years as Scientific Director of the NIMH Intramural Research Program at the NIH. He has directed research […]